{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:52:12Z","timestamp":1780581132437,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.schres.2023.02.016","type":"journal-article","created":{"date-parts":[[2023,2,26]],"date-time":"2023-02-26T16:00:35Z","timestamp":1677427235000},"page":"118-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Discontinuing cannabis use: Symptomatic and functional outcomes in people with an established psychotic disorder"],"prefix":"10.1016","volume":"254","author":[{"given":"A.","family":"Waterreus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Di Prinzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ambrosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2023.02.016_bb0005","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.psychres.2019.06.023","article-title":"Association of smoked cannabis with treatment resistance in schizophrenia","volume":"278","author":"Arsalan","year":"2019","journal-title":"Psychiatry Res."},{"issue":"7","key":"10.1016\/j.schres.2023.02.016_bb0010","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/14737175.2021.1942845","article-title":"A systematic review of longitudinal studies investigating the impact of cannabis use in patients with psychotic disorders","volume":"21","author":"Athanassiou","year":"2021","journal-title":"Expert. Rev. Neurother."},{"issue":"2","key":"10.1016\/j.schres.2023.02.016_bb0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/schbul\/sbr152","article-title":"Does change in cannabis use in established psychosis affect clinical outcome?","volume":"39","author":"Barrowclough","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2023.02.016_bb0020","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/schbul\/sbu095","article-title":"The impact of cannabis use on clinical outcomes in recent onset psychosis","volume":"41","author":"Barrowclough","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"7629","key":"10.1016\/j.schres.2023.02.016_bb0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature20153","article-title":"The effects of \u03949-tetrahydrocannabinol on the dopamine system","volume":"539","author":"Bloomfield","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.schres.2023.02.016_bb0030","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/0269881116631652","article-title":"Cannabis use in people with severe mental illness: the association with physical and mental health\u2013a cohort study. A pharmacotherapy monitoring and outcome survey study","volume":"30","author":"Bruins","year":"2016","journal-title":"J. Psychopharmacol. (Oxf.)"},{"key":"10.1016\/j.schres.2023.02.016_bb0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.schres.2020.11.059","article-title":"The association of cannabis use with quality of life and psychosocial functioning in psychosis","volume":"228","author":"Bruins","year":"2021","journal-title":"Schizophr. Res."},{"issue":"11","key":"10.1016\/j.schres.2023.02.016_bb0040","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1038\/npp.2017.50","article-title":"The differential binding of antipsychotic drugs to the ABC transporter p-glycoprotein predicts cannabinoid\u2013antipsychotic drug interactions","volume":"42","author":"Brzozowska","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"16","key":"10.1016\/j.schres.2023.02.016_bb0045","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking","volume":"158","author":"Bush","year":"1998","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/j.schres.2023.02.016_bb0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1017\/S0033291705005969","article-title":"The diagnostic interview for psychoses (DIP): development, reliability and applications","volume":"36","author":"Castle","year":"2006","journal-title":"Psychol. Med."},{"issue":"1","key":"10.1016\/j.schres.2023.02.016_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1017\/S0033291713000433","article-title":"Change in cannabis use, clinical symptoms and social functioning among patients with first-episode psychosis: a 5-year follow-up study of patients in the OPUS trial","volume":"44","author":"Clausen","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2023.02.016_bb0060","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.psychres.2018.08.005","article-title":"Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: a 6-year follow-up in an inpatient cohort","volume":"268","author":"Colizzi","year":"2018","journal-title":"Psychiatry Res."},{"issue":"1\u20133","key":"10.1016\/j.schres.2023.02.016_bb0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.schres.2012.01.016","article-title":"Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study","volume":"137","author":"van Dijk","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2023.02.016_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.531763","article-title":"Antipsychotic treatment failure: a systematic review on risk factors and interventions for treatment adherence in psychosis","volume":"14","author":"El Abdellati","year":"2020","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.schres.2023.02.016_bb0075","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1017\/S0033291717000046","article-title":"Cannabis use and adherence to antipsychotic medication: a systematic review and meta-analysis","volume":"47","author":"Foglia","year":"2017","journal-title":"Psychol. Med."},{"issue":"8","key":"10.1016\/j.schres.2023.02.016_bb0080","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1176\/appi.ajp.2010.09020189","article-title":"Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization","volume":"167","author":"Foti","year":"2010","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2023.02.016_bb0085","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/schbul\/sbp126","article-title":"Cannabis and first-episode psychosis: different long-term outcomes depending on continued or discontinued use","volume":"37","author":"Gonz\u00e1lez-Pinto","year":"2011","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2023.02.016_bb0090","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1192\/bjp.187.4.306","article-title":"Cannabis use and misuse prevalence among people with psychosis","volume":"187","author":"Green","year":"2005","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2023.02.016_bb0095","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/jamapsychiatry.2013.3726","article-title":"Comorbidity of severe psychotic disorders with measures of substance use","volume":"71","author":"Hartz","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2023.02.016_bb0100","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi","year":"2013","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.schres.2023.02.016_bb0105","series-title":"Handbook of Substance Misuse and Addictions","article-title":"The effects of drugs of abuse on ABC transporters","author":"Hussein","year":"2022"},{"issue":"7","key":"10.1016\/j.schres.2023.02.016_bb0110","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","article-title":"Half a century of antipsychotics and still a central role for dopamine D2 receptors","volume":"27","author":"Kapur","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2023.02.016_bb0115","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1080\/10826080500411502","article-title":"Validity and consistency of self-reports regarding substance use in general research volunteers, including regular cannabis users and schizophrenia patients","volume":"41","author":"Kedzior","year":"2006","journal-title":"Subst. Use Misuse"},{"issue":"2","key":"10.1016\/j.schres.2023.02.016_bb0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-1781(89)90153-4","article-title":"The schedule for the deficit syndrome: an instrument for research in schizophrenia","volume":"30","author":"Kirkpatrick","year":"1989","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.schres.2023.02.016_bb0125","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/schbul\/sbm002","article-title":"Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review","volume":"33","author":"Lincoln","year":"2007","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2023.02.016_bb0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0920-9964(02)00316-X","article-title":"Insight in schizophrenia: a meta-analysis","volume":"61","author":"Mintz","year":"2003","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2023.02.016_bb0135","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/schbul\/sbn067","article-title":"Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia","volume":"35","author":"Mohamed","year":"2009","journal-title":"Schizophr. Bull."},{"issue":"8","key":"10.1016\/j.schres.2023.02.016_bb0145","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1177\/0004867412449877","article-title":"People living with psychotic illness in 2010: the second australian national survey of psychosis","volume":"46","author":"Morgan","year":"2012","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2023.02.016_bb0150","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1177\/0004867420954268","article-title":"Mental health recovery and physical health outcomes in psychotic illness: longitudinal data from the Western australian survey of high impact psychosis catchments","volume":"55","author":"Morgan","year":"2021","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.016_bb0140","series-title":"Report to North Metropolitan Health Service Mental Health and Mental Health Commission","author":"Morgan","year":"2013"},{"issue":"4","key":"10.1016\/j.schres.2023.02.016_bb0155","first-page":"323","article-title":"Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social funtioning","volume":"101","author":"Morosini","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"issue":"9","key":"10.1016\/j.schres.2023.02.016_bb0160","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1177\/0004867412440192","article-title":"Does giving up substance use work for patients with psychosis? A systematic meta-analysis","volume":"46","author":"Mullin","year":"2012","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2023.02.016_bb0165","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/eip.12542","article-title":"Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients experiencing first episode psychosis: data from the national RAISE-ETP study","volume":"13","author":"Oluwoye","year":"2019","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.016_bb0170","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2017.03.010","article-title":"Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls","volume":"194","author":"Rabin","year":"2018","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.schres.2023.02.016_bb0175","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S2215-0366(16)30188-2","article-title":"Effects of continuation, frequency, and type of cannabis use on relapse in the first 2 years after onset of psychosis: an observational study","volume":"3","author":"Schoeler","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2023.02.016_bb0180","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/schbul\/sbv154","article-title":"Cannabis use is associated with increased psychotic symptoms and poorer psychosocial functioning in first-episode psychosis: a report from the UK national EDEN study","volume":"42","author":"Seddon","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"4","key":"10.1016\/j.schres.2023.02.016_bb0185","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/acps.13081","article-title":"Stopping cannabis use benefits outcome in psychosis: findings from 10-year follow-up study in the PAFIP-cohort","volume":"140","author":"Seti\u00e9n-Suero","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"issue":"9","key":"10.1016\/j.schres.2023.02.016_bb0190","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1017\/S0033291714003092","article-title":"Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study","volume":"45","author":"Van der Meer","year":"2015","journal-title":"Psychol. Med."},{"issue":"8","key":"10.1016\/j.schres.2023.02.016_bb0195","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/0004867412450471","article-title":"Medication for psychosis - consumption and consequences: the second australian national survey of psychosis","volume":"46","author":"Waterreus","year":"2012","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.02.016_bb0200","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.schres.2020.08.009","article-title":"Changes over time in prevalence rates of past-year cannabis use by men and women with a psychotic disorder","volume":"224","author":"Waterreus","year":"2020","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.schres.2023.02.016_bb0205","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/schbul\/sbw179","article-title":"The effect of substance use on 10-year outcome in first-episode psychosis","volume":"43","author":"Weibell","year":"2017","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.schres.2023.02.016_bb0210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1192\/bjp.bp.107.046375","article-title":"Effects of cannabis use on outcomes of psychotic disorders: systematic review","volume":"193","author":"Zammit","year":"2008","journal-title":"Br. J. Psychiatry"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423000580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423000580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:51:45Z","timestamp":1760298705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996423000580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":42,"alternative-id":["S0920996423000580"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2023.02.016","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discontinuing cannabis use: Symptomatic and functional outcomes in people with an established psychotic disorder","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2023.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}